WO2007056762A2 - Grafts and stent grafts having a radiopaque beading - Google Patents
Grafts and stent grafts having a radiopaque beading Download PDFInfo
- Publication number
- WO2007056762A2 WO2007056762A2 PCT/US2006/060704 US2006060704W WO2007056762A2 WO 2007056762 A2 WO2007056762 A2 WO 2007056762A2 US 2006060704 W US2006060704 W US 2006060704W WO 2007056762 A2 WO2007056762 A2 WO 2007056762A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beading
- radiopaque
- graft
- prosthesis
- tlie
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/18—Materials at least partially X-ray or laser opaque
Definitions
- HiD-wever they may require additional mesas fdr aacho ⁇ »g,f.he graft ⁇ within.
- li.e blood vessel such as mmi e ⁇ , clampfe s or similarly ftit!i6tiOnl ' n ' g : eiea, ⁇ !nts to overcome retracti ⁇ rs
- PTFE has prqven uausus ⁇ fy advaiitage ⁇ ws ss : a material: fr ⁇ m- which ⁇ p iabrlcaie blood- vessel grails or other knplmtabteprostltss.es,..bet v a. «se PTFB is c'xiremely biQcompaiible,- causing iitd.e:cir..tid-ktmkmogeRld reaction v ⁇ ss ⁇ placed within -the humajils
- I0OO.S] lmplaniatkm of a graft into tlie vasculature ofa patient Involves very precise ieelmkfyes.
- .the device is guided io-th ⁇ diseased or damaged portion of a lilo ⁇ d vessel ⁇ via .an implantation apparatus tliat depioys-. ' the graft attlie. desired locationo ⁇ l in order to pinpoint the ' location daring deployment;, the.
- the radfopacity is pfeferably iiicorporated into tlife device or the-e ⁇ r ⁇ traHu»g r ⁇ e ⁇ iberto A, problem can arise in delivering a grail via a slveafh.. Inpai ⁇ cul ⁇ if ⁇ ere is any ijiterfereuce. betweejft tbs gratVandthe ⁇ heatli, the.
- the ⁇ n wall m ⁇ ⁇ m& ⁇ & ⁇ Q&s- of tte implant ⁇ feyke provides flexibility to the lmplmit wliMi assists' m ⁇ wmpylMj ⁇ ? of Che Implaiitakmmd tissue during impUratatioit Use/of a tki ⁇ w ⁇ l ⁇ gm ⁇ icmi pe ⁇ h ' it the maa ⁇ lacture of smaller devices>vhich ' could :be del ⁇ Fered.BS ⁇ g smM! -sizeicsiheter b&s&ta cieliv ⁇ ry system.
- Iiowevar feat, fei I'hese.thiii wail devices may be-siibject to structural ' degradafi ⁇ .a such as y kii ⁇ king s diiri ⁇ g impknMios,
- Stents have Been used in c ⁇ nlbkatioii wMi vascuIar.rgr stis ⁇ i.c. "stent gra& f " t ⁇ provide e ⁇ d ⁇ vascufatr • pr6sth.eses-whkli ar# capable of nfainfaiBiTig tii ⁇ if ⁇ : t : against Mood, ⁇ essel walls, lite use;bf gfsfb along wlili.
- ste ⁇ ts also serves to oyercome & px ⁇ b ⁇ &m found with stents where smooifi i ⁇ uscle ce ⁇ s and-other tissues ⁇ an grow Jackpot ⁇ ugb ⁇ h ⁇ . stent's .mesh-IIke- openings,, res ⁇ liipg - ⁇ n restenosis of the y$n$&L Stent grafts -ate a prosthetk- de-vice- designed t ⁇ maintain the pateaey of various vessels. M the body ?
- imh ⁇ img tl ⁇ e tracheobtoncMal- tree.; l-he dsvlce .r ⁇ include u balloon axpmidable stent encapsulated: witM ⁇ ePTFE or alterhativ ⁇ ij s $d f-expfmd ⁇ ig Nifm ⁇ l.
- JP iue ⁇ cy ⁇ /' ⁇ vMch is marketed by C-R- Bard Peripheral Vascular Im, Examples o; ⁇ -sueh.
- tMt deploys thij: ⁇ ncaps ⁇
- In ⁇ rder t ⁇ pinpoint tin l ⁇ ci ⁇ ion ⁇ ng ⁇ tfyloymoni the- operator will ge ⁇ mlly oixl ⁇ ze a
- visnalizati ⁇ of the k ⁇ iamed device is essential for itnglantation * ' follow-up i ⁇ s ⁇ >eetidd and treatom ⁇ t; ⁇ coMingiy; m ot ⁇ et to impJabt the encapsulated " stent issmg
- the radiopacity can bs incorporated, irao ihs device or the constraining member to facilitate the correct placement wuhin the vessel.
- Dhciosure of invcftti&n f ⁇ $llj A preferred ⁇ mbodimont provides a graft device with a layer ⁇ fsjmh ⁇ t Ic noii-
- mcullic muteriai huvtng a first surface and a second surface spaced apan twin thtf fuvst surface f hs grail eevlce further bcludes a beading coupled to the laver and a radiopaque agent em ⁇ lcd to tiu beadfog. ⁇ 'lofctahiy, the beading provides kuik resistance. 3D ⁇ i the coupling of the radiopaque sgsrst to ihe beading prosldex a radiopaque beading.
- the radiopaque beading prefojably dof ⁇ nes a ⁇ ibsiantialty rectangular cross-sectional area.
- the radiopaque beading includes a radiopaque material embedded in a p ⁇ lyurethane material
- the radiopaque beading meludcs s radiopaque core deposed withia a pol ⁇ tctr ⁇ fiuoroeth ⁇ lene shell.
- ⁇ Jie radiopaque material includes 20% by weight c*f Bariom Sulfate.
- the radiopaque beading is formed from aps ⁇ te havir-g about 2C ⁇ % is ⁇ taium powder.
- the radiopaque beading is formed from a paste leaving about 20*/ « to about 40% Barium Sulfate. Moxe preferably, fee radiopaque beading k a. tzpz of 40 % ianialusn powder and 60% P ⁇ VF.
- Another embodimcut pro ⁇ ides a method of forming a graft de ⁇ Ice %vbich preferably includ ⁇ s disposing & radiopaque ageni in a polymeric shell, compressing Hit radiopaque agent and shell t ⁇ form a billet extruding the billet so as to form a radiopaque beading: and wrapping the beading about & gra ⁇ material so as to define a graft device.
- a stent graft dcv ice includes a si ⁇ nt frame having a f ⁇ &. xmtc ⁇ layer and. a second outer layer disposed about a centra! axiiu.
- the stertf grail dcvkv can further include a radiopaque agent coupled to the heading.
- the eotmUn ⁇ of the radiopaque agent to the beading provides a radiopaque beading.
- fOO 141 In yci another preferred embodiment, provided is a method of forming a .stent giarl device.
- the stent graft device is formed, at least h> ⁇ » including disposing a radiopaque agent m ii poljmcrie she!, compressing the?
- radiopaque agent and shell to form a. billet, e ⁇ lmding the billet so au to form a radiopaque beading; and wrapping the beading about a graft materca) so ⁇ s to de ⁇ i ⁇ ic a grail device,
- ⁇ ®ih Another preferred er ⁇ bodimont provides a method of observing a position of a implantable pro ⁇ thesb Ia a body, 1 lie method preferably includes disposing a implantable prosthesis having s radiopaque beading in the body and exposing the bod> t ⁇ an electromagnetic eiiergj .
- ⁇ radiopaque beading coupled to a graft or stem graft device can provide the aece ⁇ ssrj- visual cues to asslsi in the Implmit&iion, fullow-up aad treatment of the ⁇ c ⁇ ice. 'I he
- radiopaque beading can also be configured to reduce kinking m a graft b ⁇ providing structural support to the implant without significant!) reducing flexibility.
- the use of the radiopaque boading esn be preferably configtirod to minimise line contact beiweon a graft and a deliveiy sheath or between a stent gsaft a»d a delivery sheath by limiting contact to Hnc contact its the area defined be t ween the radiopaque beading and the Shaath. It is believed that
- FkJ. 1 illustrates a pieibtsd grail iievice.
- FICi ⁇ is* an X-ray view of the graft device of MG.
- HG- 3 is a crofcS-aecf ions ⁇ view of ant*didr emby ⁇ menf of a radiopaque heading.
- FIG. (> ulusirsiit.es iatx ⁇ f ⁇ fcr ehibodiment br&prefeed gMT device
- FIG; 7 illustrates -yet mipther ctnbodime»f of z ⁇ preferred gfr ' afi device, ⁇ iW2fl TlQ, S illustiaies.a pretested ste ⁇ tgraft. with- radiopaque beading. pM!28f ' FICL 91S as X-ray view of the ste ⁇ it graft with radi ⁇ paqusvbeadmg ⁇ f FI ⁇ . B;
- FIG, 10 is a citfes-s ⁇ cti ⁇ i ⁇ al- viewdf yet ano ⁇ er radiopaque beadmg.
- f 0031 J FIGS. ! 1 , 11 A, and 11 E are various perspective Md crdss-seet ⁇ oa] views of another stenigrafl having ⁇ i radiopaque bsadsiig.
- FIG. !2 is an. illustrative .fluoroscopic imagp.ofa sjent.graii ' haviBg a ' beadmg. formed by :a combkati ⁇ of jxilyi ⁇ rdliaiie and a radiopaque agent,
- the device 10 Is prel ⁇ rably a gjatl device %ti ⁇ its ouisr siiiface T2 prefcftibtly detl ⁇ es a substantially txibi ⁇ iar mepber sbo ⁇ f a ee ⁇ tral axis L-L o.f tho.dsvies 10.
- the device IO delines a substanlMly cire ⁇ iliir • perpendicular .to ills cemi-al a ⁇ js s aitliougk other eross-secttonalgeometrles are possible such as,. tor .exampie,-r ⁇ C-i& ⁇ gi ⁇ !ar or oval
- the device 10 is preferably eoafj
- the- -device 10 can be- snbstiintially s
- radiopaque agent tO ' jstovlde a vim ⁇ U indicator to an operator viewing the device- 10 ' Under ' flaor ⁇ seopis obsemtio. ⁇ as seen for example m Fl ⁇ . IA. More- spec-Mealy. t ⁇ « beading with radiopaque agent, ⁇ e. the- radiopaque beading 1.4j .provides as. operator with a Visual indicator to determine: or verify tlie.Iqcatkn a ⁇ id./or ofk ⁇ tation of the- dtn ⁇ cq IO upon implan£atio» ina.blood vessel ⁇ ? other tissue.. The radiopaque.
- beading 14 is prelbfab!y : ⁇ .und about the outer s ⁇ «.f ace- .12 so as U) gttb ' sumiMiy -drt ⁇ umcribe- ihe ; cefeai.ax ⁇ s of- tile device 10.
- Aker ⁇ ati.vely i ,-tiie radiopaque Beading; can be disposed on ih&- oixmt ' smfm® .12 sq as to be substantial iy t ⁇ one side of the central axis.
- "Hie radiopaq e beading foitlier preferably forms aconti ⁇ no . us wrapping about the.
- tiie.radiopaque beading 14 can fee formed by a.serles of ⁇ egmenls aligned about the outer surface- 12 * Furtherlft fee aHtmatlvei the r adi ⁇ .paqise -.bbading 14 am be formed by wp1tirdit> s of individual rings.
- jl ⁇ , & tmg of beading . may be siibstaniiallj :r ⁇ eiasignlar or circular ⁇ so long as ⁇ ns ring -sMsnes a.s ⁇ fiicleM lntemytlal space to be disp ⁇ sed about, the device 10.
- Ersferabiy, the radlo- ⁇ paq ⁇ e ' beSdmg..14 is fceii.cftl.3y wrapped about the oirier s ⁇ r&ce •
- the device .10 can fee a tubaiar member :macle from, a graft. materia! which caa .be a ⁇ tJ-m ⁇ talKe.Bi&te ⁇ aL Frefembly, tiie graft .material is expanded pol ⁇ tetraOuoroetIiyle ⁇ e ⁇ ePTFE) 5 but alternative n ⁇ -metdHc:.mate ⁇ als are : possib!e.for1briiiing the ⁇ mke W such as, for example:, .Dsesro ⁇ v, p ⁇ lyes ⁇ r, poIytetraOu ⁇ roethyleae ⁇ P ' rFE ⁇ ., ePTFB;, potyurethimfe; p ⁇ ljurethiHKt- ⁇ rea, slbxase, and. combinations thereof..
- the ip.almal can fncl ⁇ d.e
- tlienoii-meta.lllc mate ⁇ al is preferably fomiulated mt ⁇ :&
- f ⁇ r sample 'circular, oval or polygonal
- beaming 14 Is diii) ⁇ nsi ⁇ e ⁇ i so as to have : a: le ⁇ gtir of abbiit 1 -millimeter a ⁇ d a width of about ' 500 microns, Ppenab!>% ih.& -elongated ⁇ e of the-
- the radidpaqoe beading ⁇ 4 is pr ⁇ feralilv mads of & Bioc ⁇ ipatible poiyufeliiauo ⁇ M ⁇ ria! siith. ' as, for exat ⁇ gl ⁇ , Ca ⁇ ' thaae ⁇ PC-3575 by Novb ⁇ n, Ino, .(Th ⁇ rmedics l>ivisk>:n ⁇
- the Carbofcme preferably ' has a .72 Shore ⁇ hardness aiicl.ihe Barmm i$. pjr ⁇ .s ⁇ nt : at 20% by weight Sulfate -greater than Jib%:.is :' ⁇ «fe ⁇ eai' ' to- provide : radiopsdl ⁇ .
- tJie conc ⁇ tratioi ⁇ of Barium Sutfafceus ⁇ .e. beading :14 ranges fmi ⁇ j. about 20% to about 40% tc prdvicie tile tMi ⁇ padty.
- The- radiopaque beading .14 is preferably forMed by extru ⁇ ioa.
- &e Cartethasie PC-3575 Material and 20% by Barium Sulfate are combined in a &)ntpos ⁇ i ⁇ : resi ⁇ or paste in which the Bjir ⁇ um Sulfate is preferably dispersed réellep-ugbout/the p ⁇ lyurelhaue material.
- the ⁇ composite paste . is preferably loaded In a press device to .compress
- a:- billet.. Tie Billet is then preferably extxu ⁇ ed iq.lomi the radiopaque po.h'uretha ⁇ .e beading i4.
- fe a preferred me ⁇ oS-of coupling, the beading 14 ' to ibs-Outer surface 1.2 ⁇ fths.
- the device .IQ, fJie. beading 14 is preloaded oslo the outer sur ⁇ aes 12, More specilically,. the beadmg 14 is placed under, tension,- preferably about 500 grams of farce, abi ⁇ ' the outer surface 12..oFthe grail vthicl ⁇ omi betemporarily mounted to a.maad ⁇ i ⁇ L Preferably, the spacing between adjacent windings of the beading 14 is aboiti I mllHi ⁇ ietsr to abcmt 2- millimeters, As previously sxea of. die beadipg ls. engaged 6r coupled to. the.outer.su?facie 12.
- the solvent is preferably applied fey spj'ayisg or coating and preferably :by pulling die " beading, through a solvent, bath.
- FlO. IA shows # fluoroscopic ox X-my view of the xtevkts 10 with radiopaque
- the .beaded.gr# assembly is removed from tlie- solvent ajad &e ..solvent evaporated b
- the beaded g ⁇ ftassembly is preferably dried in oven at- ⁇ 0 °C for rn ⁇ elve hours to mmove tlie solvent completely.
- Th& short dippiag time is pR ⁇ erably designed to boiidthe beading to
- acetainiide may also be alternatively ⁇ sed, Sblvonts.that evappnuer.rapidiy tm most
- the outer layer 16' is ; preferably ⁇ PTPB so as to provide a ⁇ . ⁇ eFl'Fl ⁇ beadr ⁇ g .14' with desired.- peeling properties, as is provideeHn fenowjB/ beaded products s ⁇ ch as, Ibr.exsBiptej CEi ⁇ rrERFLEX® graft, by Bard Periphem!
- the P FFl ⁇ reslr s can be- further mixed and healed, with other sniiable bic- aeine- maie ⁇ al as part ⁇ faii optional compounding process, bor example, the FTHv sesin uui be compounded with a suitable hydruxyapatiie (HA) material to produce a beading materia! for uiereased Hocomp ⁇ tibilJiy ⁇ ind HoactH ity is order to, for example promoie endothelial cell growth far the reduction of intlmal hsperplasia.
- HA hydruxyapatiie
- the resin can be poured into an inner barrel ofapresomier b) directing Ii through ⁇ funnel which is fit to the outside of the itmor barrel,
- FiG. 4 illustrates a preferred cmbodmien? of a divided preform barrel 40 -which can be used in preforming a resin into a co ⁇ iptessed cylinder.
- the divided prsform barrel 40 preferably includes an outer holknv c>Kndiicai inemher 42. on optional inner hollow eyliiidrieal member 44.
- the inner hollow cy ⁇ nd ⁇ cal member 44 can be coftce ⁇ tiicali) cosst ⁇ hed uithin the outer holkm cylindrical member 42. Details of a similar process are shown and
- the PTFO resb can be p ⁇ arsai within a First area 52 located between the oote? hallow cylifidric ⁇ member 42 and a solid cylindrical member 46, Tii£ first ares 5 ⁇ can be
- radiopaque materia! such a?., for example, a 20% by -weight Barium Sulfate compound to form ihc radiopaque core 1 S*.
- ⁇ MUS] b one ⁇ >f the preferred embodiments, (he outer hollow cylindrical member 42 has it radius greater than the radius ⁇ f the inner huil ⁇ m cylindrical member 44.
- a preferred embodiment of the preform barrel 40 can have a radius ⁇ >r approximately 1 ,5 inches, lhe secondary area 48 between the inner hollow cylindrical member 44 arid ⁇ he central solid cylindrical member 46 can ba%e s radium of approximate!) 0,38 inches dit' :nticr hollow cylindrical member 44 can liuve a 0.0?
- a radiopaque paste or resin can be partial! ⁇ or fully embedded in a portion of the inner surface of lhe PTM" rssin w iihout the use of mi inner divider merahe? 44.
- I. he radiopaque paste can be formed from a tantalum powder.
- thm radiopaque pasre can be formed ixom a skt ⁇ percent (t?0%) tantalum paste eomblned witli a» eP'I i/K paste.
- ⁇ ddtioaal ⁇ y other suitable maltinal? caii be utilised to (br ⁇ the radiopaque paste, for example, gold or titaa ⁇ um.
- file radiopaque paste can be formed from a Baiium S ⁇ liaic mixtiiro.
- the radiopaque paste can he include an eP ' I Fh pasts mixed WUh twenty to foriy pcrceni (20-40%) Barium Sultaie. 1 « a preferred ymbodimexU, tbs i& ⁇ h ⁇ que paste i# formed into an elongated strip that can be disposed along the length of the inner s ⁇ rtaee of the- ITFB resin.
- the radiopaque paste cau form a plurality of radiopaque elements that e-an be aligned along the inner s ⁇ iriaee of the PTM: resb along Its
- The. radiopaque: paste can be formed into any shape ⁇ r ' fb ⁇ n.
- the paste can be fote ⁇ ecba ' S sutures,. ilireacls aftd.-other small pieces such as- ⁇ i ⁇ s- disposed, anywii&t- within !hi > PlTErsskt
- the e ⁇ tjM ⁇ i ⁇ s or d ⁇ iigated strip of . radiopaque material embedded in the iiftier surface of ⁇ e FfFE fe ⁇ aim provide the radiopaque core l8 f to the. operator viewing the
- the. preform, bmx ⁇ 40, the..inner eylindt ⁇ cal member 44 (if ysed ⁇ , ' the outer cylindrical member 42 ? -and the center solid cylindrical mei»b ⁇ r 46 of the divided pre fccm bsTjfej 40 are. removed to. ⁇ btaiu a compressed.eyliader or billet of material.
- the dividers witMn.th-e preform barrel may be remoVed : prior to oompressioft s without .disturbing- the interface between tile dif ferejit « ⁇ r ⁇ oads ?
- The-c ⁇ ftlpmsss&l eylinder or h ⁇ ' h ⁇ i having an oiitcr FTFE layer arid radiopaque 1 core is preferably co-ex
- the compressed cylinder of. material is plae ⁇ d wltlim an extrusion barrd.
- radiopaque beading P' can be bonded or coupled to a graft cbvke 10. in a preferred method Jot- bonding the uFIF ⁇ . radiopaque beading 14' to & grail device H), ePTKF
- the graft 10 and beading 14" can ⁇ e sintered at a temperature to f ⁇ so ihe beading 14' with the grail surfaces 12.
- Use siniermg temperatures can range from about 340 6 C to aboiu 380 0 C and preferably from about 355 °C to
- Hie tape can be formed with a preferred composite resin of about 60% tantalum as a radiopaque agent and 40% FTFE of polymeric material. Alternatively, otter polymeric and radiopaque agents can be used.
- the tantalxais m ⁇ PTFE composite is preferably extruded ami expanded three iimQn to form the radiopaque tape 14". Further in the alternatives an «rtexpan>Jed tape can be employed.
- the tinexpanded tape can provide more radi ⁇ -opacit) as compyrcd to ⁇ p ⁇ i ⁇ dcd tsp ⁇ pre_ajmabL> due to reduction of density ofradio-opaque r ⁇ atc ⁇ aL
- the tapd 14 * ' is preierably homid or coupled io s graft device 10 by wrapping the tape i 4" about a grau vtevicc 10 a «d s ⁇ attjruig tlis assembly to fuse the radiopaque tape 14'' to the device 10.
- Ihe tape 14" is prefefubiy bound to the device i ⁇ by sintering the assembly at 340-380 ft C preferabh at 355 N X' to 365 0 C for 0.5 ro 5 minutes, and preferably for 1-2 minutes.
- 10 e&ix be preferably formed by extruded ' .
- ePTF E materia! along -with a ⁇ adiopaq ⁇ e beading:204, 304, 1 ' hatiS; a radiopaque beading can-, be. bonded by sintering -or solvent bonding to at kast ⁇ ne of the luminal and abkaviihai sui-feces of the- grafts: (2 " 00 or 300). Additional examples of various; grails.,
- IS ⁇ WSS ⁇ Bh ⁇ fwxi Ip P ' ⁇ gnre 8 is ⁇ preferred, -es ⁇ b ⁇ dr ⁇ ent of an iiBplantabte prosthesis deyfc-s, ⁇ iior ⁇ pre&rably.
- T.h ⁇ device .100 is preferably eoMfgured for migrdtion t& ⁇ ugh a- Mood vessel to engage., .for dsampb f aMenosb, (0056)
- the stent grail 10(5 probably has a beading 104 to provide structural rigidity to ⁇ ® .stent 100. More preferably, the beading 104 includes oris coupled io a radiopaque a.gmt io form ⁇ radiopaque beading 104 to provide an operator with a visual locution or ⁇ cntatiou indicaior during aad following implantation of the implant 100 in ⁇ blood v ⁇ -ssel.
- the 5 radiopaque heading ! 04 is disposed within tlic stent grail ! 00 so as Uv substantially circumscribe the central axis.
- the radiopaque beading is preferably disposed between the inner aisd outer layers of the stent gral ⁇ to define the contours of the device 100,
- the radiopaque beading 104 further preferabh forms a coathuious wrapping aboat the cental axis of the device 100 so as t ⁇ form a continuous contour line on the outer surface 102 of the device 100.
- the radiopaque beading further preferabh forms a coathuious wrapping aboat the cental axis of the device 100 so as t ⁇ form a continuous contour line on the outer surface 102 of the device 100.
- radiopaque beadmg 104 can be formed by a series of segments aligned abom the outer surface 102. Further in the alternai ⁇ e. the radiopaque beading 104 cm be formed by « piarsliu of Individual rings dimensioned cmd coul ⁇ gur ⁇ d to be disposed about the device 100 and ⁇ space apart along the centra! axis. Each of the plurality of rings can define its own geometric shape. for example, a ring of bcadmg may be substantiai ⁇ y reeta ⁇ gular or circular so long as the ring
- the radiopaque beaiing 104 is preferably helically ound about ihc stent graft
- the helical wrapping of tlic radiopaque beading 104 can maximize coverage oi ' tho surface 12 ⁇ hIk r ⁇ hiimmng the overall surface area of the beading 104 t ⁇ ierohy minimi/'itig the contact between the device 100 and any sheath used to install the deuce 100,
- AB cxur ⁇ plary delivery sheath includes FLUEK €Y# by Bard Peripheral Vascular, Tempe, AZ- The contact between the device 100 and ⁇ it deliver ⁇ ' sheath can minimize the force required io pull the sheath over die device 100 during
- contour lines that provide additional visual cues to the user during and after implantation.
- m untwisted implanted dtruce 100 with preferred radiopaque beading 104 optimaHy appcars as a series of parallel along ihti central axis of the device 100.
- ConvmeK, am i-vvJMitig or bencU ⁇ g in tlie device 100 wou ⁇ i appear as converging line? m the ladlopaquc beading 104.
- radiopaque beading 104 can be employed such as, for example, forming distinct circular radi.opa.que beading about the outer surface 102 along axial length >-n"the dexiee 100.
- the circular radiopaque beading 104 caft be substantially
- the beading 104 can be elongated strips of radiopaque hiding radially spaced about the central axis of the device 100.
- a ⁇ s long as * J ⁇ ordinal observer can determine f ⁇ at ihi Jines provided by the radiopaque beading 104 in a fluoroscopic display inetliuin has a darken or higher contract image than the remainder of the device HKK tlien the ⁇ kliopaeity of the beading 104 would be deemed io be greater than a mmitm*m level needed for the beading to function a ⁇ * a radiopaque ⁇ w&or in a body.
- ⁇ lter ⁇ ath ⁇ a machine vision with the abii ⁇ tv to peeogoi?e discrete levels of contrast can be utilised to provide an objective indicator of
- ShO 1 VM in FiO. 8& is a. ⁇ ' ⁇ oss-sectional view of one e.mtx ⁇ liment of the device 1 OC) v&ih stem 101. encapsulated by Inner beading 1.04;
- the radiopaque. beading 1.04 is preferably rectangular m cro$Srsectimi.ta;proyido the maximum contact -surface &r coupling to the device.1,0.
- the.ke&ding 104 can t?$ &nj other geometry in cross-section, such ': M f fo?
- the • eio ⁇ igate ' d $ ⁇ is of the beading.104 Forms the interlace ; • between. the radibpaijue bidding 104 and the e&M ⁇ r siMsce 302 M ifee devic € .100.
- the beading 104 is substa ⁇ itialiy circular in cr ⁇ ss-se&ion, mid the diameter of ' the beading.14 lis? preferably about 0X>?
- Tfie radiopaque beading J 04 can be fomied.by variety of .techniques lacltidmg exm?sio ⁇ ,.I ⁇ jeUk>5i uioicli ⁇ g, solVerrt casting /m ⁇ the like..
- the radiopaque ' bfeaiding ' 104 can be ⁇ ade ftofn other biocompatible pQ3.ytners.such as, for- exa. ⁇ ple,,pacri>n., polyester, PTFE, e : FTEl? s polycarbonates,
- -24- cyliadei preferably containing 200 milliliters TIiF so as to expose all surfhce of the stent ⁇ raft assembly to the U lW
- the assembly can be exposed to THF for 30 seconds to 5 minuter more prefercbl) t ⁇ 1 mi g rate,
- the exposure time is controlled so tus to pornut bonding of poh-tirdkme beading io the e ⁇ VHi encapsulation layers without substantially U ⁇ cjitolvmg the beading snateicJ.
- the boack*d assembly can be takes out and air dj i «I for 30 minute* and then cried 1» c ⁇ on U y r "0 0 C tor 12 hou ⁇ s. If the eP fi'l- encapsulation material is sintereds no ⁇ dditional sintering step is needed, av ihe poly ⁇ r ⁇ thaac beading holds the encapsulation layers kjgciher- 10064J
- Another prefcrred embodiment ⁇ fihe radiopaque beading 104 is $h * )vui in FlC- 10 « ⁇ !
- radiopaque heading 104' a&vmg an outer luaicnal layer of so ⁇ -radiopaque material i I6 ! surrouiivllng a iatlioque core 118 ! -
- the o ⁇ ier layer 16' is preferably ePTPh so as to nrm Mt* an eP FFIi beading 104 With dosired f eclmg properties in knows beaded products such * ss
- S ⁇ oh polymcik materials include, for example, I )acron, polyester, polyurethane, PTFfL polvcarboBiues, polysulfonc. polyethylene, ⁇ o!ypropvk ⁇ «, p ⁇ lvuretba ⁇ c- ;uca, ⁇ iloxatfeg. ajtd eumbi ⁇ tiOBs thereof TM radiopaque core 118 * is preferah)> 2 ⁇ % by ⁇ weight of Barium Sulfas sal, material.
- the radiopaque core 118' can he m ⁇ (h from otli.ee radiopaque agents including Umtalum, tungsten, gold, stiver or oiher metallic powders or salts such as ealdum or Il ⁇ .salt
- the ePTH ⁇ beading 104' can be made b> ⁇ variety of suitable tcokmques, such as * lot example, by extrusion of elTFh and a ⁇ o ⁇ tahle radiopaque Biatcriai Q$ descflhed earlier io iorm a m ⁇ ular extrudatc or beading.
- radiopaque paste ' can ' , be ifo ⁇ nied from a ⁇ ;rii%l«m powder, '
- the radiopaque paste ⁇ can be f ⁇ ined from. &.
- the-xadiojsaque paste can be include ast-sPTFB pifete .mixed with akjut-tvventy to about fert% ! ':perce ⁇ .t (20-40.% ⁇ Bariimi Sulfate.. M. ⁇ . preferred effibtHi ⁇ iient tl-ie radiopaque, paste is f ⁇ miecl ⁇ i ⁇ mi el ⁇ agaied strip that eati.be disposed along, the length of the inner .surfaee of the PTFE t ⁇ n. Alternatively ot in : addi ⁇ ki ⁇ to ? the radiopaq tie.
- the- paste CM be formed.-as suoli as disks di$ppsed ' aiy where within ⁇ is FIFE resm.
- e ⁇ ibedded in the ⁇ xitm surface of the ⁇ TFE resin can provide- the radiopaque qr ⁇ e..1 !. ⁇ ' i ⁇ - the operator viewing the bsa ⁇ mg: 104' uB ef iiaorosc ⁇ py,
- A- second bio ⁇ 5ompatible ' flexible tubular member 25. is thes preferably loaded o.ver t ⁇ e -first
- the tubidar shaped s ⁇ pp ⁇ ri memfe ⁇ ?r,23 preferably includes a ⁇ t ⁇ u skailm to that desq ⁇ bet! In 0.3, Fat Nos, 4,733,665; 40 ⁇ a,941 ; 6 S 053 J43; SJm ⁇ $6; 6,572,641 is mcQrporatediiiits.enlimty by .reference Th ⁇ stent utilized ibr the memte 22 can. bea IMkro ⁇ e&pandabkvsienlv seli-e ⁇ panding stem ' or mem ⁇ ty ⁇ k ⁇ $ ⁇ plasticstejit.
- the tubular Hse ⁇ «fes 24, 26-nm ptakmhly. fu ⁇ together.. ⁇ eB ⁇ apsuIat ⁇ the supdortniembet* 22>
- the iob.uksy members 24 3 26 of stsnt-grsph, 100 are: prefeabiy formed by extrnd ⁇ ig a biOei.of expanded the -first sm& second biocompatible flexible tubukr members 24 s. 26 ' .iimy also .-be made. ⁇ f unexpaiided.
- the tabular members 24. 26 cmi further aife ⁇ iatively be- femed frbhi 0-l ⁇ .r 1 jio ⁇ -inetaliic iisaleriais g ' iJd ⁇ as,. for example. I3acr6.&.
- FI0 ⁇ 1 IB is a,c ⁇ oss ⁇ eetiom ⁇ l view ⁇ t -the . ' stent graft 100 OfFIG, 11 prior to fusing -the: grail or tubular members 24, 26 " to tie expansion membe ⁇ 22 to form the device 100; ' The.
- ⁇ he;t ⁇ h ⁇ lar siipp ⁇ rt member 22 preferably, a stent,- stent ft ame or similarly constructed stactus-ev forays- the Middle layer j ocated.at the centerof th ⁇ slant g ⁇ a ⁇ 100.
- O ⁇ e location can be tte cMter s ⁇ $rla.e ⁇ ::of the:- inner-member .?4.-
- Another location can be osr.the outer suriace of the stent 22, - ⁇ ?.- shown, in F1G ⁇ I l A.
- Yet another location can be .oa the outer surface of the .outer member 26, Ixi each of these locations, -the heading 1.04 is spirally wrapped about a : to ⁇ gitt ⁇ 1i ⁇ ia! axis ⁇ gtf-e ⁇ ctends tkm ⁇
- the feading 10.4 ' is • wrapped and bonded to the ⁇ uter surlaee of the
- tubular 22 is a sfe ⁇ t fraimvihie -fetiaiidisecond ePTPE- 0 iiibuiarmambsrs 24 S 26 fire fused, tp one aiiptlier tiirp ⁇ ig ⁇ i ' the openi ⁇ gi?;b.etwsei ⁇ iii.e struts tif the steal m ⁇ between &e ⁇ pi ⁇ pes of winding- of fke ' b ⁇ adihg ⁇ 04, f!3fO70j
- the : preferred teehi ⁇ gues fer fosing the radiopaque beadlng-betwee ⁇ the itsb ⁇ lar members 14.26 maj vary depending upon, the .configuration aad/br materials !b.riiili%; the-
- h ⁇ i other aprotk solvents : ⁇ nn be used.
- the other solvents or soj:ve»t Biktures ihM cai ⁇ be used include, ac-e.to.ne.. dloxtms, dmleiky! scetami ⁇ le,.diippthyi ' sulfoxide, ⁇ -
- IB ose embodibent a 10.0 Mi ⁇ il tiiick 6 millimeter diameter, graft ⁇ vhll 60% lantalt ⁇ m Um -(2 millimeter wide and 50-90..t ⁇ Scr-o.n iiikk) -ivsts extr ⁇ d ⁇ l
- smtace. 1 he filament and gr ⁇ il are preferably sintered to produce ⁇ mtahim marking on the gMT ⁇ surface ihai Ls visible in x-ray imaging.
- the i ⁇ lametn mcrv also be spiral) wound on a *>te ⁇ U graO sufi ⁇ ice.
- piefembh fo ⁇ «sc tlio radiopaque beading 14 * has an outer ePTFH fhc gra ' J i3eading/styj «/gra ⁇ ⁇ sse ⁇ bly Is healed at sinte ⁇ ag tempetatutes to form a phjhica! bond between the layers.
- the sintering temperatures can iange fiom abn ⁇ t j 00 0 C to abcn ⁇ 300 °C ⁇ aid orelexably lrom about I Ot ) 0 C to about 200 0 C.
- tlie prosthesis can Include hydsanyapst ⁇ te oa both its luminal and ahiur ⁇ mal surfaces Further, the cP 1 FH layers ma> a!st> be or jiOincd together around the ends of the u ⁇ ar ⁇ ied stem (hereby e ⁇ tirelx encasing tlits stem b hoth tlie radial mid longitudinal directions.
- the resulting stent grail I Od and mdiopaque h&almg ean he loaded oni ⁇ a suitable dcliveiy ⁇ c ⁇ ke such as, for example, I N S Patent Ko.
- Patent - Application- Publfcati ⁇ JxNo, 2004-0015228 which w mcorpotaied ifr Ifex ⁇ ntiiety by reference.
- mi ordinary observer can ⁇ 1ete : rn ⁇ uie thai the. Hn.es provMM by the ; rai3iopac
- Suchtimt ⁇ he tape is about 2 mi ⁇ im ' etisrs wide witii-s-thicl ⁇ iess ranging, from about IDO microns to- about . ⁇ 50..m ⁇ cro ' ns,
- the (ape can be f ⁇ ' mled with a preferred c ⁇ n ⁇ posii& resin - ⁇ f about .60% ' tauJalum as a radiopa ⁇ te.&gent. ancl:4 ⁇ % FTFE of polymeric ipateiiaL Alteitiatiwly, ⁇ thsr poiyperic 1 and .
- the stsnt grafi of this ⁇ .mfo.otfmie ⁇ t has the appearance of -about h&if ' of the sterft being encapsulated, by members 24 and 2(> ⁇ with about half ol " the stent being ⁇ xpds ⁇ d m'.b ' aie,- Tfcuse of the ra ⁇ iiopai
- hybrid st ⁇ Bt-graft allows for a-generaily precise piacenie ⁇ t ⁇ f the hybrid- sicat graft
- radiopaque beading allows applicant to we ' re ptMiously Unavailabie; For example, the. beading -allows for JoM/cr loading "slid deployr ⁇ e ⁇ t
- bioaclive agents include, (kit are not limited, to) pharmaceuti ⁇ -.ag ⁇ its such &%ihf example, iiftii-iJr ⁇ l ⁇ feMiye ⁇ miimuotic age.ats - m ⁇ diiig natural products swk m vines a&ak ⁇ ds (i.e
- .5 m ⁇ deprives cells which do not.have the capacity to syn&esize their O ⁇ V: ⁇ asparagme); .antiplatelet agents ...such as . G(GP) iyiJ ⁇ a mhihi'tors a ⁇ i ⁇ vitrotiecda receptor antagonists;- alkylating.
- agents suck as nitrogen, .mustards (a ⁇ eeMoreihami ⁇ e, cyclophossphafaid ⁇ atjd aiiaiogSy. ⁇ ieipMil ⁇ . ⁇ , chlorambucil), et ⁇ iyknimmes and ⁇ ieth ⁇ 3 hiidam!nea(liexamethylmelamirie mid thioteps), alkyl . sBifoiiafes-
- Birtdsoureas (cammstiae (BCNU) ⁇ iid aaSi(>gs R strepfe>zoc?H), trazones - CDTIG); aati-prblilferai-ve/ani ⁇ aitotic antimetabolite such as IbIIc add analogs (methotrexate);, py ⁇ mkliite analogs (ituoromwL fl ⁇ suridine, and cytarabka), purine: ⁇ malogs.
- acetic acids (iid ⁇ metk ⁇ cin, sull ⁇ dac, mid etodalae), fieteroarj'! acetic acids •• ⁇ t ⁇ lmetm, diclofenac s - and keiwolac), axylpmpi ⁇ mc. aeids. ⁇ lfeupf ojfea. m ⁇ . derivatives), : aalhtamlte acids, (jiiafeitjjjniio
- radiopaque beading ste»l ffaxne ⁇ ork, w ⁇ other design parameters e$ ⁇ - he atilized w.ith the : g.rat ⁇ device 100.
- Furthe ⁇ re. tlie radiopaque beading provides additional.
- .tnodHkaiioHS are wlthm the vMatioBs oltlie described er ⁇ kxliments; Accordingly, ii.k. iute ⁇ ded ' that the .present.mvention not be llniitedto tfee described; embodiments, but that ⁇ i hiw ⁇ the full seope defined by the., iatigyage-.of tlie foilowirig claims,- .and eqm ⁇ ale-nts.-thereol " .
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Optics & Photonics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008540338A JP2009514656A (ja) | 2005-11-09 | 2006-11-09 | 放射線不透過性ビーディングを有する移植片及びステント植皮 |
| CA002626601A CA2626601A1 (en) | 2005-11-09 | 2006-11-09 | Grafts and stent grafts having a radiopaque beading |
| EP06839788A EP1945139A4 (en) | 2005-11-09 | 2006-11-09 | IMPLANTS AND STENT PROSTHESES WITH AN X-RAY COATING |
| US12/092,561 US20090171436A1 (en) | 2005-11-09 | 2006-11-09 | Grafts and stent grafts having a radiopaque beading |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73472605P | 2005-11-09 | 2005-11-09 | |
| US60/734,726 | 2005-11-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007056762A2 true WO2007056762A2 (en) | 2007-05-18 |
| WO2007056762A3 WO2007056762A3 (en) | 2008-01-10 |
Family
ID=38024085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2006/060704 Ceased WO2007056762A2 (en) | 2005-11-09 | 2006-11-09 | Grafts and stent grafts having a radiopaque beading |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090171436A1 (enExample) |
| EP (1) | EP1945139A4 (enExample) |
| JP (2) | JP2009514656A (enExample) |
| CA (1) | CA2626601A1 (enExample) |
| WO (1) | WO2007056762A2 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2209445A4 (en) * | 2007-10-10 | 2010-11-10 | Bard Inc C R | RUST-RESISTANT VASCULAR STENT GRAFT |
| JP2011508648A (ja) * | 2008-01-02 | 2011-03-17 | アボット カルディオバスキュラー システムズ インコーポレーテッド | 放射線不透過性バイオセラミック粒子を備えたポリマー−バイオセラミック複合材から形成されるステント |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU733053C (en) * | 1998-02-24 | 2001-11-29 | Boston Scientific Limited | High flow rate dialysis catheters and related methods |
| US20050131520A1 (en) * | 2003-04-28 | 2005-06-16 | Zilla Peter P. | Compliant blood vessel graft |
| US7998188B2 (en) | 2003-04-28 | 2011-08-16 | Kips Bay Medical, Inc. | Compliant blood vessel graft |
| ES2375566T3 (es) | 2003-04-28 | 2012-03-02 | Kips Bay Medical, Inc. | Injerto venoso distensible. |
| US20050216043A1 (en) * | 2004-03-26 | 2005-09-29 | Blatter Duane D | Stented end graft vessel device for anastomosis and related methods for percutaneous placement |
| CA2577108A1 (en) | 2004-08-31 | 2006-03-09 | C.R. Bard, Inc. | Self-sealing ptfe graft with kink resistance |
| CA2610896C (en) | 2005-06-17 | 2014-07-08 | C.R. Bard, Inc. | Vascular graft with kink resistance after clamping |
| CA2626598A1 (en) | 2005-11-09 | 2007-05-18 | C.R. Bard Inc. | Grafts and stent grafts having a radiopaque marker |
| US20080051759A1 (en) * | 2006-08-24 | 2008-02-28 | Boston Scientific Scimed, Inc. | Polycarbonate polyurethane venous access devices |
| US9198749B2 (en) | 2006-10-12 | 2015-12-01 | C. R. Bard, Inc. | Vascular grafts with multiple channels and methods for making |
| US8257325B2 (en) | 2007-06-20 | 2012-09-04 | Medical Components, Inc. | Venous access port with molded and/or radiopaque indicia |
| WO2009012395A1 (en) | 2007-07-19 | 2009-01-22 | Innovative Medical Devices, Llc | Venous access port assembly with x-ray discernable indicia |
| EP2180915B2 (en) | 2007-07-19 | 2025-02-19 | Medical Components, Inc. | Venous access port assembly with x-ray discernable indicia |
| US8906081B2 (en) | 2007-09-13 | 2014-12-09 | W. L. Gore & Associates, Inc. | Stented vascular graft |
| WO2009052506A1 (en) * | 2007-10-19 | 2009-04-23 | Navilyst Medical, Inc. | Recirculation minimizing catheter |
| US20100256546A1 (en) * | 2009-04-03 | 2010-10-07 | Davis Scott A | Polycarbonate Polyurethane Venous Access Devices Having Enhanced Strength |
| US20110071500A1 (en) * | 2009-09-21 | 2011-03-24 | Navilyst Medical, Inc. | Branched catheter tip |
| US8328760B2 (en) * | 2010-01-11 | 2012-12-11 | Angiodynamics, Inc. | Occlusion resistant catheter |
| US9050435B2 (en) | 2011-03-22 | 2015-06-09 | Angiodynamics, Inc. | High flow catheters |
| US9713704B2 (en) | 2012-03-29 | 2017-07-25 | Bradley D. Chartrand | Port reservoir cleaning system and method |
| US9574349B2 (en) * | 2013-05-13 | 2017-02-21 | Hawkeye Pedershaab Concrete Technologies, Inc. | Post-tensioning concrete pipe wrap |
| US10166321B2 (en) | 2014-01-09 | 2019-01-01 | Angiodynamics, Inc. | High-flow port and infusion needle systems |
| EP3202433A1 (de) * | 2016-02-04 | 2017-08-09 | Berlin Heart GmbH | Auslassgraft sowie system umfassend eine blutpumpe und einen auslassgraft |
| US20230346577A1 (en) * | 2022-03-31 | 2023-11-02 | Boston Scientific Scimed, Inc. | Anti-migration stent |
| US20240225869A1 (en) * | 2023-01-05 | 2024-07-11 | Merit Medical Systems, Inc. | Apparatuses and methods of hybrid stent prostheses |
| CN116549171A (zh) * | 2023-07-12 | 2023-08-08 | 苏州美创医疗科技有限公司 | 人工血管 |
Family Cites Families (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3105492A (en) * | 1958-10-01 | 1963-10-01 | Us Catheter & Instr Corp | Synthetic blood vessel grafts |
| US3677800A (en) * | 1970-03-18 | 1972-07-18 | Gen Electric | Anti-thrombogenic coatings and products |
| SE392582B (sv) * | 1970-05-21 | 1977-04-04 | Gore & Ass | Forfarande vid framstellning av ett porost material, genom expandering och streckning av en tetrafluoretenpolymer framstelld i ett pastabildande strengsprutningsforfarande |
| US3962153A (en) * | 1970-05-21 | 1976-06-08 | W. L. Gore & Associates, Inc. | Very highly stretched polytetrafluoroethylene and process therefor |
| US4130904A (en) * | 1977-06-06 | 1978-12-26 | Thermo Electron Corporation | Prosthetic blood conduit |
| CA1147087A (en) * | 1977-12-21 | 1983-05-24 | David Goldfarb | Graphite impregnated prosthetic vascular graft materials |
| JPS6037734B2 (ja) * | 1978-10-12 | 1985-08-28 | 住友電気工業株式会社 | 管状臓器補綴材及びその製造方法 |
| US4226886A (en) * | 1979-02-16 | 1980-10-07 | Micro-Cel Systems, Inc. | Self-metering liquid retentive pad and process for producing same |
| US4604762A (en) * | 1981-02-13 | 1986-08-12 | Thoratec Laboratories Corporation | Arterial graft prosthesis |
| US4550447A (en) * | 1983-08-03 | 1985-11-05 | Shiley Incorporated | Vascular graft prosthesis |
| EP0157178B1 (en) * | 1984-03-01 | 1988-11-30 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Artificial vessel and process for preparing the same |
| US4619641A (en) * | 1984-11-13 | 1986-10-28 | Mount Sinai School Of Medicine Of The City University Of New York | Coaxial double lumen anteriovenous grafts |
| US4718907A (en) * | 1985-06-20 | 1988-01-12 | Atrium Medical Corporation | Vascular prosthesis having fluorinated coating with varying F/C ratio |
| US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
| US4739013A (en) * | 1985-12-19 | 1988-04-19 | Corvita Corporation | Polyurethanes |
| US4743252A (en) * | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
| DE3778195D1 (de) * | 1986-04-07 | 1992-05-21 | Agency Ind Science Techn | Antithrombogenisches material. |
| US5061276A (en) * | 1987-04-28 | 1991-10-29 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
| US4816339A (en) * | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
| US4810749A (en) * | 1987-05-04 | 1989-03-07 | Corvita Corporation | Polyurethanes |
| US5024671A (en) * | 1988-09-19 | 1991-06-18 | Baxter International Inc. | Microporous vascular graft |
| US5464438A (en) * | 1988-10-05 | 1995-11-07 | Menaker; Gerald J. | Gold coating means for limiting thromboses in implantable grafts |
| US4973609A (en) * | 1988-11-17 | 1990-11-27 | Memron, Inc. | Porous fluoropolymer alloy and process of manufacture |
| US4955296A (en) * | 1988-12-01 | 1990-09-11 | Barlow James L | Incinerator grate assembly |
| JP2753722B2 (ja) * | 1988-12-23 | 1998-05-20 | ジャパンゴアテックス株式会社 | 生体用電極 |
| US5201314A (en) * | 1989-03-09 | 1993-04-13 | Vance Products Incorporated | Echogenic devices, material and method |
| US4955899A (en) * | 1989-05-26 | 1990-09-11 | Impra, Inc. | Longitudinally compliant vascular graft |
| US5152782A (en) * | 1989-05-26 | 1992-10-06 | Impra, Inc. | Non-porous coated ptfe graft |
| US4990138A (en) * | 1989-07-18 | 1991-02-05 | Baxter International Inc. | Catheter apparatus, and compositions useful for producing same |
| US5229431A (en) * | 1990-06-15 | 1993-07-20 | Corvita Corporation | Crack-resistant polycarbonate urethane polymer prostheses and the like |
| CA2038605C (en) * | 1990-06-15 | 2000-06-27 | Leonard Pinchuk | Crack-resistant polycarbonate urethane polymer prostheses and the like |
| US5116360A (en) * | 1990-12-27 | 1992-05-26 | Corvita Corporation | Mesh composite graft |
| US5102402A (en) * | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
| DE4111914A1 (de) * | 1991-04-12 | 1992-10-15 | Peter Neuenschwander | Werkstoff |
| US5462781A (en) * | 1991-06-14 | 1995-10-31 | W. L. Gore & Associates, Inc. | Surface modified porous expanded polytetrafluoroethylene and process for making |
| US5192310A (en) * | 1991-09-16 | 1993-03-09 | Atrium Medical Corporation | Self-sealing implantable vascular graft |
| US5866217A (en) * | 1991-11-04 | 1999-02-02 | Possis Medical, Inc. | Silicone composite vascular graft |
| FR2688401B1 (fr) * | 1992-03-12 | 1998-02-27 | Thierry Richard | Endoprothese expansible pour organe tubulaire humain ou animal, et outil de mise en place. |
| US5571166A (en) * | 1992-03-19 | 1996-11-05 | Medtronic, Inc. | Method of making an intraluminal stent |
| US5354329A (en) * | 1992-04-17 | 1994-10-11 | Whalen Biomedical, Inc. | Vascular prosthesis having enhanced compatibility and compliance characteristics |
| US5269810A (en) * | 1992-06-19 | 1993-12-14 | W. L. Gore & Associates, Inc. | Patch electrode |
| DE4226810C1 (de) * | 1992-08-13 | 1994-01-27 | Theodor Dipl Ing Krall | Schläuche und andere Gegenstände aus Kunststoffen für den medizinischen Bedarf, die von Keimen nicht besiedelbar sind und Verfahren zu ihrer Herstellung |
| US5628782A (en) * | 1992-12-11 | 1997-05-13 | W. L. Gore & Associates, Inc. | Method of making a prosthetic vascular graft |
| US5716395A (en) * | 1992-12-11 | 1998-02-10 | W.L. Gore & Associates, Inc. | Prosthetic vascular graft |
| US5453235A (en) * | 1993-01-29 | 1995-09-26 | Impra, Inc. | Method of forming dual porosity FTFE tubes by extrusion of concentric preforms |
| DE4303181A1 (de) * | 1993-02-04 | 1994-08-11 | Angiomed Ag | Implantierbarer Katheter |
| JPH09501585A (ja) * | 1993-08-18 | 1997-02-18 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | 薄肉でシームレスの多孔質ポリテトラフルオロエチレンチューブ |
| WO1995008354A1 (en) * | 1993-09-24 | 1995-03-30 | Takiron Co., Ltd. | Implantation material |
| US5609624A (en) * | 1993-10-08 | 1997-03-11 | Impra, Inc. | Reinforced vascular graft and method of making same |
| US5639278A (en) * | 1993-10-21 | 1997-06-17 | Corvita Corporation | Expandable supportive bifurcated endoluminal grafts |
| US5527353A (en) * | 1993-12-02 | 1996-06-18 | Meadox Medicals, Inc. | Implantable tubular prosthesis |
| US5507769A (en) * | 1994-10-18 | 1996-04-16 | Stentco, Inc. | Method and apparatus for forming an endoluminal bifurcated graft |
| US5817017A (en) * | 1994-04-12 | 1998-10-06 | Pharmacyclics, Inc. | Medical devices and materials having enhanced magnetic images visibility |
| DE4418336A1 (de) * | 1994-05-26 | 1995-11-30 | Angiomed Ag | Stent |
| US5556426A (en) * | 1994-08-02 | 1996-09-17 | Meadox Medicals, Inc. | PTFE implantable tubular prostheses with external coil support |
| US5665114A (en) * | 1994-08-12 | 1997-09-09 | Meadox Medicals, Inc. | Tubular expanded polytetrafluoroethylene implantable prostheses |
| EP0782497B1 (en) * | 1994-09-23 | 2001-07-11 | Impra, Inc. | Vascular graft containing carbon and method for making same |
| US6053943A (en) * | 1995-12-08 | 2000-04-25 | Impra, Inc. | Endoluminal graft with integral structural support and method for making same |
| US6451047B2 (en) * | 1995-03-10 | 2002-09-17 | Impra, Inc. | Encapsulated intraluminal stent-graft and methods of making same |
| WO1997021401A1 (en) * | 1995-12-08 | 1997-06-19 | Impra, Inc. | Endoluminal graft with integral structural support and method for making same |
| US6264684B1 (en) * | 1995-03-10 | 2001-07-24 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Helically supported graft |
| US5605696A (en) * | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
| US5641373A (en) * | 1995-04-17 | 1997-06-24 | Baxter International Inc. | Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft |
| US5628786A (en) * | 1995-05-12 | 1997-05-13 | Impra, Inc. | Radially expandable vascular graft with resistance to longitudinal compression and method of making same |
| US5607442A (en) * | 1995-11-13 | 1997-03-04 | Isostent, Inc. | Stent with improved radiopacity and appearance characteristics |
| US5800512A (en) * | 1996-01-22 | 1998-09-01 | Meadox Medicals, Inc. | PTFE vascular graft |
| US5747128A (en) * | 1996-01-29 | 1998-05-05 | W. L. Gore & Associates, Inc. | Radially supported polytetrafluoroethylene vascular graft |
| US5607478A (en) * | 1996-03-14 | 1997-03-04 | Meadox Medicals Inc. | Yarn wrapped PTFE tubular prosthesis |
| US5824042A (en) * | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
| US5769884A (en) * | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
| US5676146B1 (en) * | 1996-09-13 | 2000-04-18 | Osteotech Inc | Surgical implant containing a resorbable radiopaque marker and method of locating such within a body |
| US5824050A (en) * | 1996-12-03 | 1998-10-20 | Atrium Medical Corporation | Prosthesis with in-wall modulation |
| CA2229685C (en) * | 1997-02-27 | 2003-09-02 | Corvita Corporation | Modular endoluminal stent-grafts and methods for their use |
| US6026814A (en) * | 1997-03-06 | 2000-02-22 | Scimed Life Systems, Inc. | System and method for percutaneous coronary artery bypass |
| US6048362A (en) * | 1998-01-12 | 2000-04-11 | St. Jude Medical Cardiovascular Group, Inc. | Fluoroscopically-visible flexible graft structures |
| US6660301B1 (en) * | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
| JP2000116787A (ja) * | 1998-10-16 | 2000-04-25 | Piolax Inc | 医療用チューブ |
| US6200338B1 (en) * | 1998-12-31 | 2001-03-13 | Ethicon, Inc. | Enhanced radiopacity of peripheral and central catheter tubing |
| US6673102B1 (en) * | 1999-01-22 | 2004-01-06 | Gore Enterprises Holdings, Inc. | Covered endoprosthesis and delivery system |
| US6285739B1 (en) * | 1999-02-19 | 2001-09-04 | The Research Foundation Of State University Of New York | Radiographic imaging apparatus and method for vascular interventions |
| US6379381B1 (en) * | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
| JP2003509156A (ja) * | 1999-09-22 | 2003-03-11 | インプラ・インコーポレーテッド | 放射性グラフト又はカフ |
| US6387123B1 (en) * | 1999-10-13 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque core |
| US6471721B1 (en) * | 1999-12-30 | 2002-10-29 | Advanced Cardiovascular Systems, Inc. | Vascular stent having increased radiopacity and method for making same |
| DE60135577D1 (de) * | 2000-11-22 | 2008-10-09 | Bard Peripheral Vascular Inc | Verfahren zur herstellung einer röhrenförmigen struktur aus expandiertem polytetrafluorethylen mit mikrowand hoher dichte |
| US20020095205A1 (en) * | 2001-01-12 | 2002-07-18 | Edwin Tarun J. | Encapsulated radiopaque markers |
| US6480747B2 (en) * | 2001-01-16 | 2002-11-12 | Quetzal Biomedical, Inc. | Cardiac electrode catheter and method of manufacturing same |
| US20020138136A1 (en) * | 2001-03-23 | 2002-09-26 | Scimed Life Systems, Inc. | Medical device having radio-opacification and barrier layers |
| US6726696B1 (en) * | 2001-04-24 | 2004-04-27 | Advanced Catheter Engineering, Inc. | Patches and collars for medical applications and methods of use |
| SE519069C2 (sv) * | 2001-05-21 | 2003-01-07 | Cid Cardivascular Innovation D | Kirurgisk markör och ett implantat |
| US6731984B2 (en) * | 2001-06-07 | 2004-05-04 | Medtronic, Inc. | Method for providing a therapy to a patient involving modifying the therapy after detecting an onset of sleep in the patient, and implantable medical device embodying same |
| US20020198559A1 (en) * | 2001-06-26 | 2002-12-26 | Bhavesh Mistry | Radiopaque balloon |
| US6585755B2 (en) * | 2001-06-29 | 2003-07-01 | Advanced Cardiovascular | Polymeric stent suitable for imaging by MRI and fluoroscopy |
| US7060089B2 (en) * | 2002-01-23 | 2006-06-13 | Boston Scientific Scimed, Inc. | Multi-layer stent |
| US8088158B2 (en) * | 2002-12-20 | 2012-01-03 | Boston Scientific Scimed, Inc. | Radiopaque ePTFE medical devices |
| JP2004298294A (ja) * | 2003-03-31 | 2004-10-28 | Sumitomo Bakelite Co Ltd | 異物付着防止カテーテル |
| US20050015138A1 (en) * | 2003-05-22 | 2005-01-20 | Andreas Schuessler | Stent made of a material with low radio-opaqueness |
| US8021418B2 (en) * | 2003-06-19 | 2011-09-20 | Boston Scientific Scimed, Inc. | Sandwiched radiopaque marker on covered stent |
| CA2626598A1 (en) * | 2005-11-09 | 2007-05-18 | C.R. Bard Inc. | Grafts and stent grafts having a radiopaque marker |
-
2006
- 2006-11-09 US US12/092,561 patent/US20090171436A1/en not_active Abandoned
- 2006-11-09 WO PCT/US2006/060704 patent/WO2007056762A2/en not_active Ceased
- 2006-11-09 EP EP06839788A patent/EP1945139A4/en not_active Withdrawn
- 2006-11-09 CA CA002626601A patent/CA2626601A1/en not_active Abandoned
- 2006-11-09 JP JP2008540338A patent/JP2009514656A/ja not_active Withdrawn
-
2012
- 2012-11-19 JP JP2012253371A patent/JP2013059643A/ja active Pending
Non-Patent Citations (1)
| Title |
|---|
| See references of EP1945139A4 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2209445A4 (en) * | 2007-10-10 | 2010-11-10 | Bard Inc C R | RUST-RESISTANT VASCULAR STENT GRAFT |
| US10098772B2 (en) | 2007-10-10 | 2018-10-16 | C. R. Bard, Inc. | Kink resistant stent graft |
| JP2011508648A (ja) * | 2008-01-02 | 2011-03-17 | アボット カルディオバスキュラー システムズ インコーポレーテッド | 放射線不透過性バイオセラミック粒子を備えたポリマー−バイオセラミック複合材から形成されるステント |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1945139A2 (en) | 2008-07-23 |
| CA2626601A1 (en) | 2007-05-18 |
| US20090171436A1 (en) | 2009-07-02 |
| JP2013059643A (ja) | 2013-04-04 |
| WO2007056762A3 (en) | 2008-01-10 |
| EP1945139A4 (en) | 2010-01-27 |
| JP2009514656A (ja) | 2009-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007056762A2 (en) | Grafts and stent grafts having a radiopaque beading | |
| Peng et al. | Role of polymers in improving the results of stenting in coronary arteries | |
| EP1586337B1 (en) | The local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque | |
| JP5114801B2 (ja) | 生体吸収性支持フレームを有するグラフト | |
| JP4684375B2 (ja) | 医療装置 | |
| US5562922A (en) | Drug incorporating and release polymeric coating for bioprosthesis | |
| EP1722706B1 (en) | Markers for mri and x-ray visualization | |
| US20020133224A1 (en) | Drug eluting encapsulated stent | |
| US20090311304A1 (en) | Drug-loaded implant | |
| IL123622A (en) | Process for coating a stent with a medicinal preparation is released | |
| MXPA03002873A (es) | Dispositivos medicos revestidos y esterilizacion de los mismos. | |
| JP2004531331A (ja) | 薬剤投与器具 | |
| EP1824532A2 (en) | Medical devices and compositions for treating restenosis | |
| Pendyala et al. | Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing | |
| Violaris et al. | Endovascular stents: a ‘break through technology’, future challenges | |
| US20200254150A1 (en) | Endoluminal device | |
| CN112368030A (zh) | 可降解器材上的聚合物层的改进 | |
| CN102686269A (zh) | 药物洗脱复合物 | |
| US20110076315A1 (en) | Grafts and Stents Having Inorganic Bio-Compatible Calcium Salt | |
| US20070110785A1 (en) | Medical devices with proteasome inhibitors for the treatment of restenosis | |
| US20220088278A1 (en) | Covered Stent For Local Drug Delivery | |
| EP2365793A1 (en) | Medical devices with extended drug diffusion pathway | |
| LAKSHMANA PENDYALA et al. | Passive and Active Polymer Coatings for Intracoronary Stents | |
| CN106730049B (zh) | 一种生物相容性内置支架材料 | |
| CA2470709C (en) | Stent with drug release coating |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2626601 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2006839788 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2008540338 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 12092561 Country of ref document: US |